Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:889-895
Published online before print June 30, 2003, doi: 10.1161/01.CIR.0000079161.56080.22
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/7/889    most recent
01.CIR.0000079161.56080.22v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagaya, N.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagaya, N.
Right arrow Articles by Mori, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GELATIN
*MONOCROTALINE
Medline Plus Health Information
*Genes and Gene Therapy
*Pulmonary Hypertension
Related Collections
Right arrow Gene therapy

(Circulation. 2003;108:889.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells

Noritoshi Nagaya, MD; Kenji Kangawa, PhD; Munetake Kanda, MD; Masaaki Uematsu, MD; Takeshi Horio, MD; Naoto Fukuyama, MD; Jun Hino, PhD; Mariko Harada-Shiba, MD; Hiroyuki Okumura, MD; Yasuhiko Tabata, PhD; Naoki Mochizuki, MD; Yoshihide Chiba, MD; Keisuke Nishioka, MD; Kunio Miyatake, MD; Takayuki Asahara, MD; Hiroshi Hara, MD; Hidezo Mori, MD

From the Departments of Internal Medicine (N.N., T.H., K.M.) and Perinatology (Y.C.), National Cardiovascular Center, Osaka, Japan; Departments of Biochemistry (K.K., J.H., M.H.-S., H.O.), Cardiac Physiology (M.K., H.M.), and Structural Analysis (N.M.), National Cardiovascular Center Research Institute, Osaka, Japan; Cardiovascular Division (M.U.), Kansai Rosai Hospital, Hyogo, Japan; Department of Physiology (N.F.), Tokai University School of Medicine, Kanagawa, Japan; Department of Biomaterials (Y.T.), Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan; Department of Transfusion Medicine (K.N., H.H.), Hyogo College of Medicine, Hyogo, Japan; and Department of Regenerative Medicine (T.A.), Institute of Biomedical Research and Innovation, Kobe, Japan.

Reprint requests to Noritoshi Nagaya, MD, or Hidezo Mori, MD, Department of Internal Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan. E-mail nagayann{at}hsp.ncvc.go.jp or hidemori@ri.ncvc.go.jp

Received December 3, 2002; revision received April 17, 2003; accepted April 18, 2003.

Background— Circulating endothelial progenitor cells (EPCs) migrate to injured vascular endothelium and differentiate into mature endothelial cells. We investigated whether transplantation of vasodilator gene-transduced EPCs ameliorates monocrotaline (MCT)-induced pulmonary hypertension in rats.

Methods and Results— We obtained EPCs from cultured human umbilical cord blood mononuclear cells and constructed plasmid DNA of adrenomedullin (AM), a potent vasodilator peptide. We used cationic gelatin to produce ionically linked DNA-gelatin complexes. Interestingly, EPCs phagocytosed plasmid DNA-gelatin complexes, which allowed nonviral, highly efficient gene transfer into EPCs. Intravenously administered EPCs were incorporated into the pulmonary vasculature of immunodeficient nude rats given MCT. Transplantation of EPCs alone modestly attenuated MCT-induced pulmonary hypertension (16% decrease in pulmonary vascular resistance). Furthermore, transplantation of AM DNA-transduced EPCs markedly ameliorated pulmonary hypertension in MCT rats (39% decrease in pulmonary vascular resistance). MCT rats transplanted with AM-expressing EPCs had a significantly higher survival rate than those given culture medium or EPCs alone.

Conclusions— Umbilical cord blood–derived EPCs had a phagocytosing action that allowed nonviral, highly efficient gene transfer into EPCs. Transplantation of AM gene-transduced EPCs caused significantly greater improvement in pulmonary hypertension in MCT rats than transplantation of EPCs alone. Thus, a novel hybrid cell–gene therapy based on the phagocytosing action of EPCs may be a new therapeutic strategy for the treatment of pulmonary hypertension.


Key Words: pulmonary heart disease • natriuretic peptides • gene therapy • endothelium




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Umar, Y. P. de Visser, P. Steendijk, C. I. Schutte, E. H. Laghmani, G. T. M. Wagenaar, W. H. Bax, E. Mantikou, D. A. Pijnappels, D. E. Atsma, et al.
Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1606 - H1616.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J H W Distler, Y Allanore, J Avouac, R Giacomelli, S Guiducci, F Moritz, A Akhmetshina, U A Walker, A Gabrielli, U Muller-Ladner, et al.
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells
Ann Rheum Dis, February 1, 2009; 68(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Satoh, Y. Fukumoto, M. Nakano, K. Sugimura, J. Nawata, J. Demachi, A. Karibe, Y. Kagaya, N. Ishii, K. Sugamura, et al.
Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1
Cardiovasc Res, January 1, 2009; 81(1): 226 - 234.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667.
[Full Text] [PDF]


Home page
CirculationHome page
G.-P. Diller, S. van Eijl, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bedard, J. S. R. Gibbs, J. Bauersachs, et al.
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension
Circulation, June 10, 2008; 117(23): 3020 - 3030.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. L. Spees, M. J. Whitney, D. E. Sullivan, J. A. Lasky, M. Laboy, J. Ylostalo, and D. J. Prockop
Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension
FASEB J, April 1, 2008; 22(4): 1226 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Satoh and B. C. Berk
Circulating smooth muscle progenitor cells: novel players in plaque stability
Cardiovasc Res, February 1, 2008; 77(3): 445 - 447.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X.-X. Wang, F.-R. Zhang, Y.-P. Shang, J.-H. Zhu, X.-D. Xie, Q.-M. Tao, J.-H. Zhu, and J.-Z. Chen
Transplantation of Autologous Endothelial Progenitor Cells May Be Beneficial in Patients With Idiopathic Pulmonary Arterial Hypertension: A Pilot Randomized Controlled Trial
J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1566 - 1571.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Sahara, M. Sata, T. Morita, K. Nakamura, Y. Hirata, and R. Nagai
Diverse Contribution of Bone Marrow Derived Cells to Vascular Remodeling Associated With Pulmonary Arterial Hypertension and Arterial Neointimal Formation
Circulation, January 30, 2007; 115(4): 509 - 517.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Ishikawa, M. Eguchi, M. Wada, Y. Iwami, K. Tono, H. Iwaguro, H. Masuda, T. Tamaki, and T. Asahara
Establishment of a Functionally Active Collagen-Binding Vascular Endothelial Growth Factor Fusion Protein In Situ
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1998 - 2004.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Marumo, H. Uchimura, M. Hayashi, K. Hishikawa, and T. Fujita
Aldosterone Impairs Bone Marrow-Derived Progenitor Cell Formation
Hypertension, September 1, 2006; 48(3): 490 - 496.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. C.H. Hsieh, C. MacGillivray, J. Gannon;, F. U. Cruz, and R. T. Lee
Local Controlled Intramyocardial Delivery of Platelet-Derived Growth Factor Improves Postinfarction Ventricular Function Without Pulmonary Toxicity
Circulation, August 15, 2006; 114(7): 637 - 644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. D. Zhao, D. W. Courtman, D. S. Ng, M. J. Robb, Y. P. Deng, J. Trogadis, R. N. N. Han, and D. J. Stewart
Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 182 - 189.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kanki-Horimoto, H. Horimoto, S. Mieno, K. Kishida, F. Watanabe, E. Furuya, and T. Katsumata
Implantation of Mesenchymal Stem Cells Overexpressing Endothelial Nitric Oxide Synthase Improves Right Ventricular Impairments Caused by Pulmonary Hypertension
Circulation, July 4, 2006; 114(1_suppl): I-181 - I-185.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sata
Role of Circulating Vascular Progenitors in Angiogenesis, Vascular Healing, and Pulmonary Hypertension: Lessons From Animal Models
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1008 - 1014.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Satoh, Y. Kagaya, M. Nakano, Y. Ito, J. Ohta, H. Tada, A. Karibe, N. Minegishi, N. Suzuki, M. Yamamoto, et al.
Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in Mice
Circulation, March 21, 2006; 113(11): 1442 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Kataoka, N. Nagaya, T. Satoh, T. Itoh, S. Murakami, T. Iwase, Y. Miyahara, S. Kyotani, Y. Sakai, K. Kangawa, et al.
A Long-Acting Prostacyclin Agonist with Thromboxane Inhibitory Activity for Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. J. Dzau, M. Gnecchi, A. S. Pachori, F. Morello, and L. G. Melo
Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases
Hypertension, July 1, 2005; 46(1): 7 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Nagaya, H. Mori, S. Murakami, K. Kangawa, and S. Kitamura
Adrenomedullin: angiogenesis and gene therapy
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1432 - R1437.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Uchimura, T. Marumo, O. Takase, H. Kawachi, F. Shimizu, M. Hayashi, T. Saruta, K. Hishikawa, and T. Fujita
Intrarenal Injection of Bone Marrow-Derived Angiogenic Cells Reduces Endothelial Injury and Mesangial Cell Activation in Experimental Glomerulonephritis
J. Am. Soc. Nephrol., April 1, 2005; 16(4): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. D. Zhao, D. W. Courtman, Y. Deng, L. Kugathasan, Q. Zhang, and D. J. Stewart
Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow-Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease
Circ. Res., March 4, 2005; 96(4): 442 - 450.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Iwase, N. Nagaya, T. Fujii, T. Itoh, H. Ishibashi-Ueda, M. Yamagishi, K. Miyatake, T. Matsumoto, S. Kitamura, and K. Kangawa
Adrenomedullin Enhances Angiogenic Potency of Bone Marrow Transplantation in a Rat Model of Hindlimb Ischemia
Circulation, January 25, 2005; 111(3): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Itoh, N. Nagaya, S. Murakami, T. Fujii, T. Iwase, H. Ishibashi-Ueda, C. Yutani, M. Yamagishi, H. Kimura, and K. Kangawa
C-type Natriuretic Peptide Ameliorates Monocrotaline-induced Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Hristov, W. Erl, S. Linder, and P. C. Weber
Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro
Blood, November 1, 2004; 104(9): 2761 - 2766.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Matsui, T. Shimosawa, K. Itakura, X. Guanqun, K. Ando, and T. Fujita
Adrenomedullin Can Protect Against Pulmonary Vascular Remodeling Induced by Hypoxia
Circulation, May 11, 2004; 109(18): 2246 - 2251.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Stewart, Y. D. Zhao, D. W. Courtman, N. Nagaya, T. Horio, K. Miyatake, Y. Chiba, K. Kangawa, M. Kanda, J. Hino, et al.
Cell Therapy for Pulmonary Hypertension: What Is the True Potential of Endothelial Progenitor Cells? * Response
Circulation, March 30, 2004; 109(12): e172 - e173.
[Full Text] [PDF]


Home page
CirculationHome page
N. Tokunaga, N. Nagaya, M. Shirai, E. Tanaka, H. Ishibashi-Ueda, M. Harada-Shiba, M. Kanda, T. Ito, W. Shimizu, Y. Tabata, et al.
Adrenomedullin Gene Transfer Induces Therapeutic Angiogenesis in a Rabbit Model of Chronic Hind Limb Ischemia: Benefits of a Novel Nonviral Vector, Gelatin
Circulation, February 3, 2004; 109(4): 526 - 531.
[Abstract] [Full Text] [PDF]